T3D Therapeutics, Inc. — Form D

T3D Therapeutics, Inc. of Research Triangle Park, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-06. The offering totals $7.5M, of which $6.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2022-09-06
Form: D
Accession: 0001579600-22-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $7.5M
Amount sold: $6.0M
Remaining: $1.5M
Investors: 23
Date of first sale: 2022-08-26
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-457972

Issuer

Name: T3D Therapeutics, Inc.
CIK: 0001579600
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2013
Address: 68 T.W. Alexander Drive, Research Triangle Park, NC, 27709
Phone: 919-949-0517

Officers, directors & promoters (11)

Name	Role	Location
Barry Buzogany	Director	Research Triangle Park, NC
John Didsbury	Director	Research Triangle Park, NC
John Golden	Director	Research Triangle Park, NC
David Keim	Director	Research Triangle Park, NC
Charles Lineberry	Director	Research Triangle Park, NC
Tom Mendell	Director	Eatontown, NJ
Donald Parker	Director	Research Triangle Park, NC
John Didsbury	Executive Officer	Research Triangle Park, NC
John Didsbury	Promoter	Research Triangle Park, NC
Tom A Mendell	Director	Research Triangle Park, NC
John A Golden	Director	Research Triangle Park, NC

Other filings by this issuer (7)

Filed	Form	Offering	Sold
2019-11-01	D	$15.0M	$15.0M
2018-03-12	D	$18.0M	$6.0M
2018-01-12	D	$1.0M	$711K
2016-03-14	D/A	$3.8M	$1.2M
2015-03-13	D	$3.0M	$115K
2014-03-14	D	$2.5M	$661K
2013-08-05	D	$550K	$437K

More